View Agent
| Agent Info | |
| Agent: | MSC2156119J |
| Synonyms: | EMD-1214063 |
| Drug Status For Certain Diseases: | solid tumors(phase I) |
| Classification: | an oral selective c-Met inhibitor, |
| Target: | Hepatocyte growth factor receptor |
| KEGG Pathway: | Cytokine-cytokine receptor interaction Adherens junction Bacterial invasion of epithelial cells Focal adhesion Rap1 signaling pathway Melanoma Central carbon metabolism in cancer Endocytosis PI3K-Akt signaling pathway Pathways in cancer Transcriptional misregulation in cancer Axon guidance MicroRNAs in cancer Ras signaling pathway Epithelial cell signaling in Helicobacter pylori infection Renal cell carcinoma Proteoglycans in cancer |
| Wiki Pathway: | Semaphorin interactions Focal Adhesion Signaling Pathways in Glioblastoma miR-targeted genes in lymphocytes - TarBase TGF beta Signaling Pathway Signaling of Hepatocyte Growth Factor Receptor Extracellular vesicle-mediated signaling in recipient cells miR-targeted genes in epithelium - TarBase miR-targeted genes in squamous cell - TarBase miR-targeted genes in muscle cell - TarBase |